253
|
852
|
7svoA |
Dpp8 in complex with ligand iced-1 |
231
|
846
|
7svlA |
Dpp9 in complex with ligand iced-2 |
221
|
846
|
7svnA |
Dpp9 in complex with ligand iced-1 |
173
|
727
|
7xnmA |
Structure of porcine dipeptidyl peptidase 4 inhibitory peptide complex |
251
|
852
|
7svmA |
Dpp8 in complex with ligand iced-2 |
255
|
844
|
7zxsA |
Crystal structure of dpp9 in complex with a 4-oxo-b-lactam based inhibitor, a295 |
252
|
846
|
7zxsB |
Crystal structure of dpp9 in complex with a 4-oxo-b-lactam based inhibitor, a295 |
220
|
850
|
7oz7A |
Crystal structure of dpp8 in complex with a 4-oxo-b-lactam based inhibitor, l84 |
226
|
850
|
7or4A |
Crystal structure of dpp8 in complex with a 4-oxo-b-lactam based inhibitor, b142 |
222
|
850
|
7a3kA |
Crystal structure of dpp8 in complex with a b-lactam based inhibitor, a296.1 |
220
|
850
|
7a3iA |
Crystal structure of dpp8 in complex with a 4-oxo-b-lactam based inhibitor, lmc375 |
191
|
846
|
7a3fA |
Crystal structure of apo dpp9 |
229
|
852
|
7a3gA |
Crystal structure of dpp8 in complex with a 4-oxo-b-lactam based inhibitor, 91 |
223
|
850
|
7ayrA |
Crystal structure of dpp8 in complex with a 4-oxo-b-lactam based inhibitor, b115 |
229
|
850
|
7ayqA |
Crystal structure of dpp8 in complex with a 4-oxo-b-lactam based inhibitor, b114 |
229
|
850
|
7a3jA |
Crystal structure of dpp8 in complex with a 4-oxo-b-lactam based inhibitor, a272 |
231
|
850
|
7a3lA |
Crystal structure of dpp8 in complex with a 4-oxo-b-lactam based inhibitor, a241 |
185
|
846
|
7jkqA |
Human dpp9-card8 complex |
196
|
846
|
7jn7A |
Human dpp9-card8 complex |
191
|
846
|
6x6aA |
Cryo-em structure of nlrp1-dpp9 complex |
209
|
846
|
6x6cA |
Cryo-em structure of nlrp1-dpp9-vbp complex |
198
|
721
|
6y0fA |
Structure of human fapalpha in complex with linagliptin |
242
|
850
|
6trwA |
Crystal structure of dpp8 in complex with the eil peptide (slrflfegqriadnh) |
234
|
850
|
6trxA |
Crystal structure of dpp8 in complex with 1g244 |
213
|
728
|
5ismA |
Human dpp4 in complex with a novel 5,5,6-tricyclic pyrrolidine inhibitor |
194
|
725
|
5y7jA |
Crystal structure of human dpp4 in complex with inhibitor2 |
189
|
726
|
5y7hA |
Crystal structure of human dpp4 in complex with inhibitor3 |
199
|
727
|
5zidA |
Crystal structure of human dpp-iv in complex with hl2 |
199
|
725
|
5y7kA |
Crystal structure of human dpp4 in complex with inhibitor1 |
205
|
727
|
5j3jA |
Crystal structure of human dpp-iv in complex with hl1 |
199
|
727
|
3swwA |
Crystal structure of human dpp-iv in complex with sa-(+)-3-(aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyphenyl)- 2-methyl-5h-pyrrolo[3,4-b]pyridin-7(6h)-one |
209
|
727
|
5kbyA |
Crystal structure of dipeptidyl peptidase iv in complex with syr-472 |
218
|
728
|
5i7uA |
Human dpp4 in complex with a novel tricyclic hetero-cycle inhibitor |
214
|
727
|
4qzvA |
Bat-derived coronavirus hku4 uses mers-cov receptor human cd26 for cell entry |
212
|
850
|
6eosA |
Dpp8 - apo, space group 19 |
229
|
850
|
6eooA |
Dpp8 - apo, space group 20 |
248
|
850
|
6eopA |
Dpp8 - slrflyeg, space group 20 |
199
|
845
|
6eorA |
Dpp9 - 1g244 |
232
|
850
|
6eotA |
Dpp8 - slrflyeg, space group 19 |
188
|
845
|
6eoqA |
Dpp9 - apo |
218
|
728
|
6b1eA |
The structure of dpp4 in complex with vildagliptin |
214
|
728
|
6b1oA |
The structure of dpp4 in complex with vildagliptin analog |
223
|
724
|
5yp2A |
Crystal structure of dipeptidyl peptidase iv (dpp iv) with dpp4 inhibitor from pseudoxanthomonas mexicana wo24 |
190
|
723
|
5yp1A |
Crystal structure of dipeptidyl peptidase iv (dpp iv) from pseudoxanthomonas mexicana wo24 |
223
|
724
|
5yp4A |
Crystal structure of dipeptidyl peptidase iv (dpp iv) with lys-pro from pseudoxanthomonas mexicana wo24 |
198
|
724
|
5yp3A |
Crystal structure of dipeptidyl peptidase iv (dpp iv) with ile-pro from pseudoxanthomonas mexicana |
197
|
724
|
4dsaA |
Crystal structure of dpp-iv with compound c1 |
196
|
728
|
4dtcA |
Crystal structure of dpp-iv with compound c5 |
201
|
724
|
4dszA |
Crystal structure of dpp-iv with compound c2 |
217
|
727
|
4a5sA |
Crystal structure of human dpp4 in complex with a noval heterocyclic dpp4 inhibitor |